We studied the effective spread of lidocaine to inactivate neural tissue in the frontal cortex of the rhesus monkey. Injections of 2% lidocaine at 4 vl/min were made while units were recorded 1 or 2 mm away. To inactivate units 1 mm away from the injection site 100% of the time, 7 vl of lidocaine had to be injected. To inactivate units 2 mm away from the injection site 100% of the time, 30 vl of lidocaine were required. Units were maximally inactivated around 8 min after the start of a lidocaine injection, and they gradually recovered, regaining most of their initial activity by around 30 min after the start of an injection. The volume of lidocaine required to inactivate neurons ]90% of the time could be estimated by the spherical volume equation, V = 4/3 pi (r) 3 . To prolong the inactivation, a slower infusion of lidocaine subsequent to an initial bolus was effective. Saline control injections had no effect. These results allow both a prediction of the timecourse of neural inactivation and an estimate of the spread of neural inactivation following injection of lidocaine into the monkey cerebral cortex. © 1997 Elsevier Science B.V.
Introduction
Neuronal blockade with lidocaine has been used to study a variety of behaviours such as eye movements (Demer and Robinson, 1982; Hikosaka and Wurtz, 1986; Lee et al., 1988; May et al., 1988) , drinking (Manani et al., 1995) , and the avoidance of noxious stimuli (Urban and Smith, 1994) . Lidocaine inactivates neurons by blocking sodium channels (Hille, 1966 (Hille, , 1977 Ritchie, 1979) . A major advantage of using this agent over the more conventional permanent lesion technique is that aside from being reversible, this technique does not have problems with compensatory neuronal effects that arise during many weeks of post-lesion recovery (Hikosaka and Wurtz, 1986) .
The effective spread of lidocaine and its timecourse of effect has not been studied systematically for different volumes in the cerebral cortex. We injected different volumes of lidocaine into the dorsomedial frontal cortex of an awake monkey while recording from neurons at different distances away from the injection site. The effective spread of lidocaine conformed to the cubic relationship, volume= 4/3 pi (radius) 3 .
Materials and methods

Subject
One adult rhesus monkey (Macaca mulatta) was used. Throughout this study food and water were freely available. After testing each day, the animal was returned to the vivarium. The monkey was provided for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the guidelines of the Massachusetts Institute of Technology Committee on Animal Care.
Surgery
The monkey was anesthetized first with ketamine (10 mg/kg) and then with pentobarbital (30 mg/kg) in preparation for sterile surgery. During surgery pentobarbital was administered intravenously. A stainlesssteel post to restrain the head during testing was attached to the skull with head bolts and acrylic cement. A recording chamber was centered and implanted at 25 mm anterior to the interaural line and 4.0 mm left of the cerebral midline. The chamber position was biased toward the left dorsomedial frontal cortex, but both hemispheres could be accessed (Fig. 1) . After surgery, the monkey was placed on a regimen of antibiotics and pain killer (buprenorphine, 1mg/ml/day) for several days.
Apparatus for infusion
Glass-coated platinum-iridium electrodes with an impedance of 0.5-3.0 megohms at 1 kHz were constructed. Impedance was measured with a 1 kHz, nanoampere tester (Bak Electronics, Inc., model A-1B), that was calibrated with a 1.0 megohm resistor. Action potentials were amplified (Bak A-1B) and filtered (Krohn-Hite 3750), displayed on a Tektronix Oscilloscope (model 5103N), and isolated with a window discriminator (Model 121 Window Discriminator, W.P. Instruments Inc).
The apparatus used to infuse lidocaine (lidocaine hydrochloride, 2% solution; Steris Laboratories, Inc., Fig. 2 . Schematic of the apparatus used to deliver the lidocaine or saline into the cortex is shown. A hydraulic-microdrive assembly held a cannula and microelectrode in parallel and pushed both through the dura into the brain. Unit activity was monitored with a microelectrode, and lidocaine or saline was infused through the needle tip of the cannula. See Materials and methods (Section 2) for other details.
Phoenix, Arizona, USA) or saline (0.9% Nacl) into the cortex is shown (Fig. 2) . Using a hydraulic-microdrive assembly, a cannula filled with a pharmacological agent accompanied by a microelectrode was pushed through the dura into the cortex. The cannula was made from a 30-gauge, 16-mm long needle that was epoxied to a 28-gauge stainless-steel tube. Polyethylene tubing (PE-50, I.D.: 0.58 mm; O.D.: 0.965 mm) was fitted to the end of the 28-gauge stainless-steel tube. About 80 cm of tubing was connected to a 100 vl hamilton syringe, fixed to an infusion pump (Harvard Apparatus Compact Infusion Pump, c 31537).
The hypodermic syringe and needle, the polyethylene tubing, and the injection cannula were filled with distilled water. The hypodermic syringe was drawn so that 3 vl of air were introduced into the cannula tip. The cannula was then filled with the pharmacological agent by drawing :50 vl of agent into it. The 3-vl airpocket between the distilled water and agent could be seen as a bubble in the polyethylene tubing. The position of this bubble and the measurement scale (in vl) on the hypodermic syringe were used to monitor the amount of agent in the injection line.
The filled cannula and a microelectrode were attached to the hydraulic-microdrive assembly. The tip of the electrode was aligned with the tip of the cannula; the tips were separated by 1 or 2 mm. The assembly was attached to the recording chamber which was filled with mineral oil. Care was taken to make sure that the bubble in the polyethylene tubing (marking the separation between the distilled water and agent) remained at the same position before and after the assembly was mounted onto the recording chamber. This assured that the mineral oil within the chamber did not enter the cannula due to the volumetric pressure exerted by the oil within the enclosed recording chamber.
The microdrive was now advanced until the recording electrode came in contact with the dura. The electrode and cannula were then pushed through the dura in 5-vm steps until units were detected. The electrode and cannula were allowed to settle for 30 min before descending further to locate units for testing.
Parametric testing
The relationship between the volume of lidocaine infused and the spread and timecourse of neural inactivation was determined. Throughout testing, the monkey, with head fixed, sat in a small illuminated room that was isolated from the infusion pump and from the equipment for unit recording. The monkey performed no task. To reduce the chances of neuronal damage no more than one injection of lidocaine or saline was done within a given test day. Fifty-two separate infusions of lidocaine and 24 separate infusions of saline were done into the dorsomedial frontal cortex. The entire experiment was conducted over a 6-month period. Once a group of units was encountered that exhibited a steady firing rate, the window discriminator was used to demarcate a lower and upper limit of voltage within which a unit's peak spike amplitude had to occur to trigger an output pulse to a PDP 11/73 computer. The lower limit of voltage was always set above the peak-topeak noise in the baseline recording signal, and the upper limit was set to include several units. Including several units contributed to the stability of the neural firing frequency over time. Large-amplitude units were excluded from the voltage window since they tended to be unstable, often expiring. The rate (in spikes/s) of unit firing was computed every minute (total number of spikes per min/60 s per min) by the PDP computer. The infusion rate of lidocaine or saline, which was controlled by the infusion pump, was held constant at 4 vl/min unless otherwise specified.
Since the firing frequency of the units at different injection sites varied, the unit activity was normalized by dividing the firing frequency at a given minute following an injection by the baseline firing frequency (Fig. 3A,B) . A value less than '1' indicated that the unit activity decreased relative to baseline and a value greater than '1' indicated that the unit activity increased relative to baseline (Fig. 3B) . Neural shutdown was defined as a drop in unit firing frequency to 20% or lower of baseline firing following an injection (i.e. a drop to 0.2 or lower on the normalized curve, Fig. 3B ).
The baseline firing rate had to be stable over many minutes before an injection was done. Since it was necessary to search for units exhibiting stable firing, the injections were often conducted at different depths below the first unit encountered on a pass. Some sites were injected more than once but each injection was always done on a different day, and such a site was never injected more than once a week.
Histology
The location of the cannula/electrode penetrations was determined by noting the location of the well relative to the arcuate sulcus and cortical midline during surgery, and by noting the electrode coordinates on a 1×1 mm grid. After all testing was completed, the monkey was overdosed with pentobarbital, perfused with 0.9% NaCl, and fixed with 4% paraformaldehyde. Guide pins were inserted into the cortex at specific positions around the recording chamber. The location of the electrode/cannula sites were estimated relative to the pins. The monkey used in this study had been used in Tehovnik et al. (1994) as monkey A.
Results
Effecti6e spread
The injection sites are depicted in Fig. 1 . The injection depths that were used, at which neurons had acceptably stable and vigorous firing rates, ranged from 0.5 to 1.5 mm below the first unit encountered on a descent. Baseline firing frequencies ranged from 10 to 50 Hz. Within minutes of the start of a lidocaine infusion, the neural firing rate dropped rapidly (Fig.  3A,B) . After that, the neural activity gradually recovered. Although eight or so injections of agent were made at the same cortical entrance point, with repeated injections there was no obvious reduction in unit activity at the sites below an entrance point.
Normalized unit activity is plotted as a function of time after a lidocaine injection for different conditions (Figs. 4 and 5) . Fig. 4A -C illustrate the effect of injecting 2, 4, and 7 vl of lidocaine when the cannula and electrode tips were spaced by 1 mm. For each volume, six separate injections (I to Vl) were performed. To achieve shutdown of the neurons (a drop in unit activity to 20% or less of baseline firing: 0.2 or less on a normalized graph) in 6 of 6 cases, 7 vl of lidocaine were necessary. The average drop in activity for the 2, 4, and 7 vl of lidocaine is shown in Fig. 4D , with 2 vl having a negligible effect on the cells and 4 and 7 vl having a large effect. Eight min following an injection of lidocaine, the neural activity did not exhibit a significant drop from baseline when 2 vl was injected (t(5)= 0.9, p\ 0.05), but did exhibit a significant drop when 4 or 7 vl was injected (t(5)= 23.6, pB 0.05; t(5)= 36.7, pB 0.05). Fig. 5A -E show the effect of injecting 4, 7, 10, 20, and 30 vl of lidocaine when the cannula and electrode tips were spaced by 2 mm. To get shutdown in 6 of 6 cases, 30 vl of lidocaine were required. The average drop in unit activity for 4, 7, 10, 20, and 30 vl of lidocaine is shown (Fig. 5F) , with the magnitude of the drop increasing systematically with volume. Eight min- utes following an injection of lidocaine, the neural activity did not exhibit a significant drop from baseline when 4 or 7 vl was injected (t(5) =1.1, p \ 0.05; t(5)= 2.2, p\0.05), but did exhibit a significant drop when 10, 20, or 30 vl was injected (t(5) = 6.1, p B 0.05; t(5) = 5.1, pB0.05; t(5) =24.5, p B0.05).
The effect of the saline injections on the average unit activity is illustrated in Fig. 6 . When the cannula and electrode tips were spaced by 1 mm, 2, 4, and 7 vl of saline had a negligible effect on the unit activity. Likewise, when the cannula and electrode tips were spaced by 2 mm, 4, 7, 10, and 20 vl of saline had a negligible effect, although the variability was greater. The 30 vl injection caused a drop in unit activity, but the drop was well above the 0.2 level on the normalized graph, the criterion used for shutdown. Eight min following an injection of saline, the neural activity exhibited a significant drop from baseline only when 30 vl was injected (t(2)= 8.0, pB0.5), but not when lesser volumes were injected.
Temporal properties
For each case where there was shutdown following a lidocaine injection, the time for a decline in unit activity to 80, 50, and 20% of baseline firing following an injection is shown in Fig. 7A . The method used to derive the times is illustrated in Fig. 3B . The average time for a drop in unit activity to 80, 50, and 20% of baseline in cases where the cannula and electrode were spaced by 1 mm was 1.3, 2.2, and 3.4 min, respectively. The average time for a drop to 80, 50, and 20% of baseline in cases where the cannula and electrode were spaced by 2 mm was 1.9, 2.9, and 4.4 min, respectively. Shutdown occurred within 5 min when lidocaine was injected with a 1 or 2 mm cannula -electrode separation.
For each case where there was shutdown following a lidocaine injection, the time for recovery in unit activity to 20, 50, and 80% of baseline following an injection is shown in Fig. 7B . The method used to derive the times is illustrated in Fig. 3B . The average time for an increase in unit activity to 20, 50, and 80% of baseline The average time for a recovery in unit activity to 20, 50, and 80% of baseline is shown for injections of lidocaine for a 1-and 2-mm cannula-electrode separation. The averages are based on data in Fig. 4a-c and Fig. 5a-e) . Data from Fig. 5a were not used since none of the curves declined to 20% of baseline. Standard errors are shown for each bar graph. A t-test revealed no significant differences (p \0.05) between the 1 and 2 mm conditions. See text for other details. in cases where the cannula and electrode were spaced by 1 mm was 12.9, 20.7, 27.2 min, respectively. The average time for an increase to 20, 50, and 80% of baseline in cases where the cannula and electrode were spaced by 2 mm was 13.3, 17.9, 23.8 min, respectively. Recovery to 80% of baseline occurred within 30 min when lidocaine was injected with a 1 or 2 mm cannulaelectrode separation.
Probability of inacti6ation
The probability of neuronal shutdown to 20% of baseline varied as a function of the volume of lidocaine injected and it varied as a function of the distance between the cannula and electrode (Fig. 8A) . Three vl of lidocaine were required for a 50% probability of shutdown when the cannula and electrode were spaced by 1 mm, and 10 vl were required for a 50% probability of shutdown when the cannula and electrode were spaced by 2 mm. The volumes of lidocaine required to achieve a 50, 70, 90, and 100% probability of shutdown at 1 and 2 mm from the cannula are illustrated (Fig.  8b) . Notice that the curve representing the volume of a sphere overlaps with the 90 and 100% probability lines for shutdown using lidocaine, suggesting that this relationship can be used to estimate the effective spread of lidocaine within cortex.
Continuous infusion
In the experiments described thus far, lidocaine was injected into the cortex at an infusion rate of 4 vl/min for less than 8 min. The cells tended to begin their recovery as early as 12 to 14 min following an injection (e.g. Fig. 7B at 20% of baseline). We next tested to see if we could extend the period of neuronal shutdown by imposing a slow drip of lidocaine after the normal 4 vl/min dose was finished. Eight vl of lidocaine was injected at 4 vl/min followed by lidocaine delivery at 0.1, 0.2, and 0.3 vl/min for 15 min (Fig. 9A) . The time Volume of lidocaine required to achieve 50, 70, 90, and 100% probability of shutdown (dashed lines) is plotted for electrode-needle tip separation (radius), as estimated from the curves in (A). The volumetric spread of a liquid from a cannula C to an electrode E is plotted (black curve) using the relationship, V=4/ 3 pi (r) 3 , where V is volume and r is radius.
of neuronal shutdown lasted between 52 and 62 min (i.e. the time the curves in Fig. 9A increased to 20% of baseline). The different drip rates used did not affect this time in any systematic way. When a low rate of lidocaine infusion was administered before the bolus was delivered, there was a slight effect (Fig. 9B) . Shutdown to 20% of baseline, however, was evident only once the normal bolus at 4 vl/min was delivered.
Discussion
Temporal properties
Neuronal shutdown following an injection of lidocaine into the dorsomedial frontal cortex was immediate, occurring within 5 min of starting an injection and recovering within 30 min. These finding coincide with previous studies where oculomotor (Demer and Robinson, 1982; May et al., 1988) and evoked potential (McGee et al., 1991) measures were used to assess the onset of an effect of lidocaine and recovery thereof.
Anywhere from 1 to 30 vl of lidocaine were injected in these studies, volumes comparable to those used in the current study. The concentration of lidocaine used in these studies was somewhat higher at 4% rather than at 2% as used in the current study. Also most injections were made into subcortical structures. The relationship between the temporal effects of lidocaine and its concentration has not been tested. It is common for investigators to use a 1 to 4% solution for inactivating neural tissue (e.g. Sandkü hler and Gebhart, 1984; May et al., 1988) .
The blocking effects of lidocaine are largely over by 30 min. Testing the behavioural effects of neuronal inactivation for 30 or so min allows one to obtain behavioural measures before, during, and after inactivation on the same day with minimal complications arising from an animal's fatigue (Sommer and Tehovnik, in press ). One, however, is restricted temporally when using lidocaine, which is not true when using agents such as muscimol (Hikosaka and Wurtz, 1985) . To overcome this problem we have found that once a bolus of lidocaine has been administered, the suppressive effects of lidocaine can be prolonged to over 1 h by continuously infusing lidocaine into the brain at a low rate (e.g. B 0.3 vl/min) for many tens of minutes.
Volumetric spread of lidocaine
The results suggest that the relationship between the volume of lidocaine (in vl or mm 3 ) and its effective spread (in mm) conforms to the cubic relationship, volume=4/3 pi (radial spread) 3 . This conclusion is based on volumes from 2 to 30 vl tested on neurons 1 and 2 mm away from a cannula tip.
While measuring the effects of lidocaine on the unit activity within the lateral geniculate nucleus, Malpeli and Schiller (1979) determined the radial spread of 20 and 50 nl of 2% lidocaine to be 100 and 200 vm. Using the cubic relationship, 20 and 50 nl of lidocaine should inactivate neurons within 170 and 230 vm from the cannula tip. By measuring changes in the current threshold of stimulation-evoked responses before and after injections of 1 or 4% lidocaine into the medulla or spinal cord, Sandkü hler and Gebhart (1984) and Sandkü hler et al. (1987) determined that 500 nl of lidocaine spreads 435 or 500 vm from the cannula tip and that 1000 nl of lidocaine spreads 750 vm from the cannula tip. Using the cubic relationship, 500 nl of lidocaine should inactivate neurons within 490 vm from the cannula tip and 1000 nl of lidocaine should inactivate neurons within 620 vm from the cannula tip. Accordingly, the cubic relationship not only accounts for the estimates of the current study that uses large volumes of lidocaine (i.e. 2 to 30 vl) but it also accounts for the estimates of other studies that use extremely small volumes (i.e. B1 vl). Fig. 10 shows that the estimates of the current study along with the estimates of Malpeli and Schiller (1979); Gebhart (1984), and Sandkü hler et al. (1987) correspond well to the cubic relationship. The number of studies estimating the effective spread of lidocaine is small. Future studies will need to be done to further ascertain the strength of the cubic relationship.
Damage
As already discussed, following an injection of lidocaine the effects are largely over by 30 min. Regardless of the volume of the injection up to 30 vl, complete neuronal recovery was typical, indicating that the neurons at a recording site 2 mm from the cannula tip were largely unaffected. We did find, however, that under these conditions, saline of 30 vl, but not 10 or 20 vl, produced significant neuronal shutdown that remained so for tens of minutes. This suggests that at an infusion rate of 4 vl/min (which was the standard used in this study) some mechanical damage due to volume displacement might occur. Although we never recorded the neural activity close to the cannula tip, Demer and Robinson (1982) have suggested that damage at the canula tip is unavoidable even at infusion rates of 1 or 2 vl/min using volumes less than 12 vl. Unlike the study of Demer and Robinson (1982) , however, our injections were never made into the same site more than once per day and the time between successive injections into one site was always greater than 1 week. Fig. 10 . The effective radial spread of lidocaine is plotted as a function of volume using a log-log plot. The individual data points (open triangles) are from (a) the current study (Fig. 8B : volumes producing 100% shutdown for cannula -electrode separations of 1 and 2 mm), from (b) Sandkü hler et al. (1987) , and from (c) Sandküh-ler and Gebhart (1984) , and from Malpeli and Schiller (1979) . The black line cutting the data points represents the volume of a sphere, r =[(3 ×V)/(4 ×pi)]
1/3 , where r is radius and V is volume.
Radioacti6e spread of lidocaine
Martin (1991) injected 1 vl of [ 14 C]lidocaine (4%) into subcortical regions of the rat brain. The radioactive lidocaine was found to spread radially from the cannula tip in coronal brain sections. The radioactive lidocaine was indistinguishable from background beyond 60 min post-injection. Our findings suggest that lidocaine is ineffective at disrupting neural activity beyond 30 min post-injection. The maximal radioactive spread of 1 vl of 4% lidocaine was estimated by Martin to be roughly 1.8 mm from the cannula tip, which was corroborated by a drop in glucose utilization. According to the cubic relationship, to inactivate tissue 1.8 mm away from the cannula tip, 24 vl of lidocaine would be required, and 1 vl of lidocaine should inactivate tissue 0.62 mm away from the cannula tip. Thus, the simple spread of lidocaine molecules is not equivalent to the effective spread of lidocaine as defined with unit recording. This indicates that the concentration of lidocaine molecules necessary for detection of the substance is less than the concentration necessary to effectively inactivate a neuron. We suggest that investigators be careful in using the spread of labelled molecules in interpreting the amount of tissue affected by the pharmacological effect of those molecules.
Inacti6ating cortical tissue in macaque monkeys
In order to inactivate a 2-mm thick cortex, two conditions are critical. First, the cannula should be positioned in the deep layers of cortex, and second, between 8 and 16 vl of lidocaine should be injected (Fig. 11) . The deep placement assures that the cannula is deep enough so as to avoid superficial injections that might fail to inactivate cortex due to leakage up the cannula shaft. A deep placement can be accomplished by pushing the cannula/electrode assembly between 1 and 2 mm below the first unit encountered on a pass. Volumes of 8-16 vl make sure that all the cortical layers are being inactivated, especially the output layers. In order to produce reliable deficits in the execution of saccadic eye movements, between 8 and 18 vl of lidocaine had to be injected deep within the frontal eye fields of macaque monkeys (unpublished observations, also see Sommer and Tehovnik, in press ). Volumes below 4 vl were ineffective at producing an oculomotor deficit. It is noteworthy that volumes less than 4 vl are sufficient to produce an oculomotor deficit following an injection of lidocaine into subcortical regions such as the superior colliculus (Hikosaka and Wurtz, 1986; Lee et al., 1988) . Whether this difference in effective volume is related to a difference in the neuronal volume devoted to oculomotor control within the frontal eye fields and superior colliculus, or whether it is related to less lidocaine leaking up the electrode shaft during deep subcortical injections, is not known. Fig. 11 . Illustrated is a 2-mm thick cerebral cortex (layers I to VI), which is the approximate thickness of macaque dorsomedial frontal cortex (Winters et al., 1969) . The layers containing cells are indicated in grey. With a cannula tip located at 1.5 mm below the first unit encountered on a pass, the volume of lidocaine injected to inactivate different portions of cortex is depicted using 2, 8, and 16 vl of lidocaine based on the relationship, volume=4/3 pi (radius) 3 .
Although lidocaine has advantages such as a quick onset, a short time of affect, and causing a complete deadening of tissue, its major disadvantage is that it inactivates axons along with the cell bodies (Fig. 11) . Lidocaine inactivates all axons terminating in or passing through an injected area of cortex. It is imperative, therefore, that lidocaine be used in combination with an agent that disables only cell bodies to verify that the effect of lidocaine inactivation can be attributed to activity of cells residing in the injected area. Muscimol is an agent that affects cell bodies without interfering with the conduction of axons. Muscimol, however, is limited given its long time of effect (Hikosaka and Wurtz, 1985; Sommer and Tehovnik, in press) and unknown effective spread properties.
Conclusion
The blocking effect of lidocaine is largely over after 30 min. The effective spread of lidocaine within neural tissue can be described using the cubic relationship, volume=4/3 pi (r) 3 . This relationship is robust for describing both small-and large-volume injections. By noting the timecourse and effective spread of lidocaine in cortical tissue, investigators will be better able the assess the significance of behavioural deficits, or lack of, arising from targeted injections of lidocaine into different cortical areas.
